Neuraxpharm and Dizlin Partner to Develop Next-Gen Therapy for Advanced Parkinson’s Disease Read more
Sagent and Qilu Forge Strategic Partnership to Boost Access to Critical Injectables in U.S. Read more
Mustang Bio’s MB-101 Receives FDA Orphan Drug Designation for Astrocytomas and Glioblastoma Read more